Taveras Arthur

Track

Insider profile

Performance

Overall performance
1.9
Performance over holding periods
1.9
30 days 90 days 120 days
Average return -35% 8.2% 15.1%
Success rate 6% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Taveras Arthur's trades of X4 Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-01-24 2025-01-24
PrS Proposed sale
70,907
347.07
US$138,479 		70,907 347.07 US$138,479
2024-10-08 2024-10-07
PlS Planned sale
77,818 +7.7%
42.20
US$4,764,446 		77,818 +7.7% 42.20 US$4,764,446
2024-10-07 2024-10-07
PrS Proposed sale
76,270
100.10
US$2,300,133 		76,270 100.10 US$2,300,133
2024-03-11 2024-03-11
PrS Proposed sale
14,235
0.90
US$12,812 		14,235 0.90 US$12,812
2024-03-11 2024-03-11
S Sale
14,235 -5.7%
0.88
US$12,552 		14,235 -5.7% 0.88 US$12,552
2024-02-12 2024-02-12
PrS Proposed sale
787
0.97
US$763 		787 0.97 US$763
2024-02-12 2024-02-12
S Sale
787 -0.3%
1.01
US$793 		787 -0.3% 1.01 US$793
2023-11-03 2023-11-01
PlS Planned sale
67,695 -21.4%
0.73
US$49,417 		67,695 -21.4% 0.73 US$49,417
2023-11-01 2023-11-01
PrS Proposed sale
67,695
0.79
US$53,553 		67,695 0.79 US$53,553
2023-03-13 2023-03-10
PlS Planned sale
16,806 -16.3%
0.84
US$14,117 		16,806 -16.3% 0.84 US$14,117
2023-02-15 2023-02-13
PlS Planned sale
928 -0.9%
0.93
US$863 		928 -0.9% 0.93 US$863